Interestingly, in contrast to the decreased protein expression of Epac2, our data showed that AKAP5 was significantly upregulated in hippocampal postmortem samples of AD patients, which was consistent with a previous study performed in hippocampal postmortem samples from AD patients [37]. This evidence concerns the gene RAPGEF4 and Alzheimer disease.